Multi-omics study of the anti-colorectal cancer mechanisms of formononetin in Hedysari Radix
The findings provide novel insights into the HR metabolome and reveal the multi-targeting roles of formononetin in CRC development, laying the foundation for developing new CRC therapeutic strategies.
Authors
- C. Chen
- Ssu-Wei Hsu
- Jun Rao (ORCID: https://orcid.org/0000-0002-5089-778X)
- Chuanju Xu (ORCID: https://orcid.org/0000-0002-6689-329X)
- So-Yi Chang
- Xiaoqun Han
- Tanxiu Chen
- Xing Wang
- Mingzi Mo
- Zhi Zheng
Institutions
- Yichun University (CN)
- Jiangxi Provincial Academy of Medical Sciences (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Jiangxi Provincial Cancer Hospital (CN)
- Jingdezhen University (CN)
- Jiangxi Provincial People's Hospital (CN)
- University of California, Davis (US)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-06
- DOI
- https://doi.org/10.3389/fphar.2025.1649691
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangxi Provincial Department of Science and Technology